Clinical Trials Logo
  1. Home
  2. Other
  3. NCT03935776

Lifestyle Modification Programme for Patients With Peripheral Arterial Disease

Peripheral Arterial Occlusive Disease Clinical Trial

Official title:
The Effect of Lifestyle and Risk Factor Modification on Occlusive Peripheral Arterial Disease Outcomes: Standard Healthcare vs Structured Programme

Clinical Trial Summary

This trial randomises patients with occlusive peripheral arterial disease, to be managed either by providing a 12-week structured lifestyle modification programme, or standard healthcare.

Clinical Trial Description

Peripheral arterial disease (PAD) affects more than 200 million of the global population. PAD represents a marker for premature cardiovascular events. Despite the high prevalence of PAD and the strong association with cardiovascular morbidity and mortality, patients with PAD are less likely to receive appropriate treatment for their atherosclerotic risk factors than those who are being treated for coronary artery disease. Because PAD represents a peripheral manifestation of atherosclerosis, most traditional and novel cardiovascular risk factors are strongly associated with this condition. Smoking, diabetes, hyperlipidaemia, hypertension, unhealthy diet, and physical inactivity were identified as significant modifiable risk factors that should be targeted for secondary prevention. Atherosclerotic risk factor identification and modification plays an important role in reducing the number of adverse outcomes among patients with atherosclerosis. Risk reduction therapy decreases the risk of cardiovascular mortality and morbidity in patients with PAD. Because of the efficacy of these techniques, several expert committees have recommended their use in patients with PAD. Despite clear guidelines, several studies have shown that patients with PAD are routinely undertreated for these risk factors, which may contribute to high rates of morbidity and mortality. Our trial will evaluate the impact of a 12-week, structured lifestyle and risk factor modification programme on medical and lifestyle risk factors modification, as well as on clinical vascular outcomes, among patients with peripheral arterial disease. We will compare these outcomes to that of standard healthcare traditionally provided to this high-risk patient group. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03935776
Study type Interventional
Source Western Vascular Institute, Ireland
Contact Wael Tawfick, MB BcH,MRCSI
Phone + 35391542535
Email wael.tawfick@hse.ie
Status Recruiting
Phase N/A
Start date June 1, 2018
Completion date September 1, 2022
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05961943 - RESPONSE-2-PAD to Reduce Sedentary Time in Peripheral Arterial Disease Patients N/A
Completed NCT02900274 - "All Comers" Post Market Clinical Follow-up (PMCF) With Multi-LOC for flOw liMiting Outcomes (LOCOMOTIVE Extended)
Withdrawn NCT01938924 - Surgical Revascularisation and Nerve Stimulation Trial N/A
Completed NCT00740207 - Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral DSA Phase 4
Active, not recruiting NCT06056193 - The SIR-POBA Bypass Trial N/A
Recruiting NCT06082466 - FRAMED Infrainguinal Venous Bypass Versus Conventional Autologous Bypass Trial N/A
Completed NCT05590182 - CO2-Angiography-Study to Evaluate Diagnostic and Safety to Patients With Peripher Arterial Stenotic or Occlusive Disease. N/A
Recruiting NCT03638115 - The VaSecure BTK Study N/A
Recruiting NCT01774058 - The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation Phase 2
Active, not recruiting NCT00566436 - Remote Endarterectomy Versus Suprageniculate Femoropopliteal Bypass N/A
Active, not recruiting NCT00863967 - Early Detection of Arteriosclerosis N/A
Recruiting NCT05586022 - Risk Factors for Adverse Outcomes of Endovascular Revascularization in Lower Extremity Arteriosclerosis Occlusion
Completed NCT02929095 - The Effect of Remifentanil-dexmedetomidine Compared With Remifentanil-midazolam on Patient's Satisfaction N/A
Completed NCT02832570 - Sildenafil Efficacy Study on Time Walk From Peripheral Arterial Desease Patients (Stade II) With Arterial Claudication Phase 3
Terminated NCT01341340 - The ABSORB BTK (Below The Knee) Clinical Investigation N/A
Completed NCT02867501 - Venous Distension in Patients With Aneurysmatic Arterial Disease N/A
Active, not recruiting NCT02460042 - Clinical Post Market Clinical Follow-up (PMCF) on Peripheral Arteries Treated With SeQuent® Please Over The Wire (OTW)
Completed NCT01855412 - Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes
Terminated NCT00717639 - Vasovist Magnetic Resonance Angiography (MRA) in Peripheral Arterial Occlusive Disease Phase 4
Completed NCT00459888 - Cryoplasty CLIMB-registry Phase 4